Journal of radiosurgery and SBRT最新文献_第7页

Field output correction factors of stereotactic cones for a diode detector: Dependence on cone size, measurement setup, reference field size and photon energy. 二极管探测器立体定向锥的场输出校正因子:依赖于锥尺寸，测量装置，参考场尺寸和光子能量。

IF 1.2

Journal of radiosurgery and SBRT Pub Date : 2022-01-01

Yongsook C Lee, Yongbok Kim

引用次数: 0

Stereotactic body radiation therapy treatment by deep inspiratory breath hold in a patient with permanent tracheostomy - Technical solution and clinical implementation - A case report. 立体定向全身放射治疗永久性气管切开术患者的深吸气屏气术-技术解决方案及临床实施- 1例报告。

IF 1.2

Journal of radiosurgery and SBRT Pub Date : 2022-01-01

Sasmita Priyadarshini Sahu, Panomali Dayakar Reddy, Susovan Banerjee, Deepak Gupta, Shyam Singh Bisht, Amarendra Amar, Tejinder Kataria

引用次数: 0

ISRS CONGRESS, NEW YORK CITY, USA, MAY 12-15, 2024. 2024年5月12日至15日，美国纽约，以色列大会。

IF 1.2

Journal of radiosurgery and SBRT Pub Date : 2022-01-01

引用次数: 0

GammaKnife radiosurgery for Fisch-classified jugulotympanic paragangliomas: Review of the measures and timing of treatment success. GammaKnife放射手术治疗fish分类颈鼓室副神经节瘤:治疗成功的措施和时机的回顾。

IF 1.2

Journal of radiosurgery and SBRT Pub Date : 2022-01-01

Federico Ampil, Anthony Sin, Donald Smith, Troy Richards

引用次数: 0

Stereotactic radiosurgery for sellar solitary fibrous tumors: Case report and literature review. 鞍区孤立性纤维性肿瘤的立体定向放射治疗:1例报告及文献复习。

IF 1.2

Journal of radiosurgery and SBRT Pub Date : 2022-01-01

Purushotham Ramanathan, Georgios Mantziaris, Stylianos Pikis, Lena Young, Chloe Dumot, Jason Sheehan

引用次数: 0

Repeat stereotactic radiosurgery for locally recurrent brain metastases previously treated with stereotactic radiosurgery: A systematic review and meta-analysis of efficacy and safety. 重复立体定向放射治疗局部复发性脑转移瘤:疗效和安全性的系统回顾和荟萃分析。

IF 1.2

Journal of radiosurgery and SBRT Pub Date : 2022-01-01

Raj Singh, Prabhanjan Didwania, Eric J Lehrer, Joshua D Palmer, Daniel M Trifiletti, Jason P Sheehan

{"title":"Repeat stereotactic radiosurgery for locally recurrent brain metastases previously treated with stereotactic radiosurgery: A systematic review and meta-analysis of efficacy and safety.","authors":"Raj Singh, Prabhanjan Didwania, Eric J Lehrer, Joshua D Palmer, Daniel M Trifiletti, Jason P Sheehan","doi":"","DOIUrl":"","url":null,"abstract":"Objectives: To perform a systematic review and meta-analysis of outcomes for patients with locally recurrent brain metastases treated with a repeat course of stereotactic radiosurgery (rSRS).Method: Primary outcomes were 1-year local control(LC) and radionecrosis (RN). Secondary outcomes were 1-year overall survival (OS) and 1-year distant brain control (DBC). Weighted random effects meta-analyses utilizing the DerSimonian and Laird methods were conducted to characterize summary effect sizes. Mixed effects regression models were utilized to analyze potential correlations between prognostic factors and outcomes.Results: In total, 347 patients with 462 brain metastases treated with rSRS were included. Estimated 1-year LC, OS, and DBC rates were 69.0% (95% CI: 61.0-77.0%), 49.7% (95% CI: 28.9-70.6%), and 41.6% (95% CI: 33.0-50.4%), respectively. The estimated RN rate was 16.1% (95% CI: 6.3-25.9%). Every 1 Gy increase in prescription dose was estimated to result in roughly 5% increase in 1-year LC (p = 0.14).Conclusions: rSRS was well-tolerated with reasonable 1-year LC and OS. Dose escalation may result in improved LC.","PeriodicalId":16917,"journal":{"name":"Journal of radiosurgery and SBRT","volume":"8 1","pages":"1-10"},"PeriodicalIF":1.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930057/pdf/rsbrt-8-10.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10516143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Stereotactic body radiotherapy in patients with adrenal gland metastases of oligometastatic and oliogoprogressive lung cancer. 立体定向放射治疗肾上腺转移性少转移性及少进展性肺癌。

IF 1.2

Journal of radiosurgery and SBRT Pub Date : 2022-01-01

Rashad Rzazade, Ngoc T Pham, Menekse Turna, Mehmet Dogu Canoglu, Esra Kucukmorkoc, Kezban Berberoglu, Hale Basak Caglar

{"title":"Stereotactic body radiotherapy in patients with adrenal gland metastases of oligometastatic and oliogoprogressive lung cancer.","authors":"Rashad Rzazade, Ngoc T Pham, Menekse Turna, Mehmet Dogu Canoglu, Esra Kucukmorkoc, Kezban Berberoglu, Hale Basak Caglar","doi":"","DOIUrl":"","url":null,"abstract":"Objective: To evaluate the efficacy and safety of stereotactic body radiotherapy (SBRT) in patients with adrenal gland metastasis (AGM) of oligometastatic lung cancer.Methods: Between June 2013 and May 2021, 44 patients with oligometastatic lung cancer (51 AGMs) were treated with SBRT. Forty-six (90%) lesions received a biological effective dose (BED10, α/β = 10) of 100 Gy. The primary endpoint was local control (LC). Local control (LC), overall survival (OS), and progression-free survival (PFS) curves were calculated by the Kaplan-Meier method.Results: The median follow-up was 23 months. The most common histology was non-small cell lung cancer (88.6%). The 1- and 2-year LC rates were both 95% and 91%, respectively. Overall survival was better in patients with solitary AGMs in univariate analysis.Conclusion: This study demonstrated that SBRT with higher BED is associated with satisfactory LC and low toxicity rates in patients with AGM of oligometastatic lung cancer.","PeriodicalId":16917,"journal":{"name":"Journal of radiosurgery and SBRT","volume":"8 4","pages":"275-282"},"PeriodicalIF":1.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322168/pdf/rsbrt-8-275.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10164552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Resection cavity dynamics and optimal timing of adjuvant stereotactic radiosurgery for resected brain metastases. 切除脑转移瘤的切除腔动力学和辅助立体定向放射手术的最佳时机。

IF 1.2

Journal of radiosurgery and SBRT Pub Date : 2022-01-01

Sujay Rajkumar, Yun Liang, Matthew J Shepard, Richard Williamson, Alexander Yu, Stephen M Karlovits, E Wegner Rodney

{"title":"Resection cavity dynamics and optimal timing of adjuvant stereotactic radiosurgery for resected brain metastases.","authors":"Sujay Rajkumar, Yun Liang, Matthew J Shepard, Richard Williamson, Alexander Yu, Stephen M Karlovits, E Wegner Rodney","doi":"","DOIUrl":"","url":null,"abstract":"Purpose: Optimal timing of SRS after surgical resection of brain metastases (BMs) remains debated but is generally advocated to occur within 4 weeks of surgery to account for cavity remodeling. Our study assesses this recommendation by examining cavity dynamics and any downstream effects on outcome.Methods: Post-operative MRIs were used to compare target lesion volumes to target volume at time of SRS. Spearman's analysis identified a relationship between the time to SRS (ttSRS) and target remodeling. The Mann-Whitney-U test compared median remodeling between groups receiving standard (≤4 weeks) and late (>4 weeks) adjuvant SRS. Kaplan Meier functions estimated probabilities of local recurrence (LR) and survival (OS). A Cox proportional hazards model (CPH) identified predictors of OS, LR, and leptomeningeal disease (LMD).Results: Median ttSRS was 32 days (3-72). A positive correlation exists when comparing ttSRS to reduction in cavity volume (0-10 weeks; p = 0.01) with no difference in median cavity remodeling between standard and late SRS groups. OS and LR rates were respectively 53.3% and 70.2% at 12 months with no difference in OS (p = 0.16) or LR (p = 0.54) between standard and late SRS groups. Subtotal resection predicted LMD (HR: 6.37; p = 0.03). No grade 3 or higher toxicity was seen in follow-up.Conclusion: Resection cavities may continue to shrink well after resection. There is no significant difference in OS or LR based on ttSRS, however, treatment factors such as the extent of resection may account for outcomes such as LMD.","PeriodicalId":16917,"journal":{"name":"Journal of radiosurgery and SBRT","volume":"8 4","pages":"247-255"},"PeriodicalIF":1.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322174/pdf/rsbrt-8-247.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10164553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

First case of posterior cranial fossa myopericytoma treated with a combined microsurgery and stereotactic radiosurgery approach: Case report and literature review. 显微外科与立体定向放射外科联合治疗后颅窝肌外皮细胞瘤1例报告并文献复习。

IF 1.2

Journal of radiosurgery and SBRT Pub Date : 2022-01-01

Riccardo Lavezzo, Salima Magrini, Marta Rossetto, Irene Coati, Angelo P Dei Tos, Matilde Cazzagon, Nicola Cavasin, Paolo M Polloniato, Anna D'Amico, Michele Longhi, Francesco Sala, Antonio Nicolato

引用次数: 0

Stereotactic body radiation therapy for metastatic urethral melanoma in a male patient. 立体定向放射治疗转移性尿道黑色素瘤1例男性患者。

IF 1.2

Journal of radiosurgery and SBRT Pub Date : 2022-01-01

Shikha Goyal, Kannan Periasamy, Shrawan Kumar Singh, Chandan Krushna Das

引用次数: 0